Order Article Reprints

Ribnikar D, Stukalin I, Bedard PL, Hamilton RJ, Jewett M, Warde P, Chung P, Anson-Cartwright L, Templeton AJ, Amir E, et al. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer. Current Oncology. 2021; 28(1):107-114. https://doi.org/10.3390/curroncol28010014

Ribnikar, Domen, Igor Stukalin, Philippe L. Bedard, Robert J. Hamilton, Michael Jewett, Padraig Warde, Peter Chung, Lynn Anson-Cartwright, Arnoud J. Templeton, Eitan Amir, and et al. 2021. "The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer" Current Oncology 28, no. 1: 107-114. https://doi.org/10.3390/curroncol28010014

Ribnikar, D., Stukalin, I., Bedard, P. L., Hamilton, R. J., Jewett, M., Warde, P., Chung, P., Anson-Cartwright, L., Templeton, A. J., Amir, E., Hansen, A. R., Heng, D. Y. C., & Lewin, J. (2021). The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer. Current Oncology, 28(1), 107-114. https://doi.org/10.3390/curroncol28010014